Monday, April 25, 2011 6:36:14 PM
SAN DIEGO--India’s leading biopharmaceutical company, Intas Biopharmaceuticals Ltd. (IBPL, www.intasbiopharma.co.in), has acquired US-based biotechnology corporation, Biologics Process Development Incorporated (BPD Inc., www.biologicspd.com), based in Poway, California. With the acquisition process underway, both Intas Biopharma and BPD Inc. are actively pursuing plans to work closely toward fulfillment of common business objectives in the area of biologics Contract Research and Manufacturing Services (CRAMS).
This development will facilitate and assist Intas Biopharma’s foray into the US market especially to expand its CRAMS business. With mutual understanding and agreement between the two companies, Dr. Scott M. Brown, Founder, President and Chief Scientific Officer of BPD, Inc., will continue as President and Chief Scientific Officer.
Expressing his view on the development, Dr. Brown said, “We are pleased to become associates with Intas Biopharmaceuticals, a leader in the area of biologics research and manufacturing in India. Jointly we complement each other on the technology front, and we at BPD Inc. are looking forward to working with Intas and exploring new technology frontiers.”
Intas Biopharma’s venture into the CRAMS business has opened up new vistas for R&D in the area of biopharmaceuticals and biosimilars. According to Dr. Dhananjay Patankar, CTO of Intas Biopharmaceuticals Ltd., “IBPL has taken up the CRAMS opportunity in the biotechnology space as a focus area with tremendous potential and is preparing to scale up its facilities. IBPL offers a unique business model for offshore clients, providing competitive advantages in terms of developing new biotech products, technology transfer and contract manufacturing in a seamless manner and at committed costs, quality, and time.”
Don't know the date of this PR...
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM